ScienceDaily (May 7, 2012) ? Elderly people with pre-diabetes and type 2 diabetes suffer from an accelerated decline in brain size and mental capacity in as little as two years according to new research presented at the joint International Congress of Endocrinology/European Congress of Endocrinology in Florence, Italy. An Australian research team led by Associate… [Continue Reading]

ScienceDaily (May 2, 2012) ? A highly toxic beta-amyloid — a protein that exists in the brains of Alzheimer’s disease victims — has been found to greatly increase the toxicity of other more common and less toxic beta-amyloids, serving as a possible “trigger” for the advent and development of Alzheimer’s, researchers at the University of… [Continue Reading]

ScienceDaily (May 2, 2012) ? A drug prescribed for Alzheimer’s disease does not ease clinically significant agitation in patients, according to a new study conducted by researchers from the U.K., U.S. and Norway. This is the first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in… [Continue Reading]